company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17876000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17876000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17876000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6432000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25650000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32082000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14206000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2726000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,692000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2034000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16240000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16240000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16240000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16240000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13200000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.23
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13200000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.23
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13210000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.23
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,89958000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,89958000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,89958000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7516000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33269000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,40785000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,49173000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2725000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,383000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2342000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,46831000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,46831000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,46831000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,46831000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13347000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.36
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37106000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.58
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34400000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:09:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.36
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13662000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13662000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13662000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10140000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40617000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,50757000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-37095000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2723000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,283000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2440000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-39535000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39535000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39535000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-39535000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13500000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.93
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13500000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.93
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13503000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:16:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.93
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16105000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16105000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16105000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12821000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,51258000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,64079000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-47974000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2934000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1706000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1358000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2586000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-50560000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50560000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50560000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-50560000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18800000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.37
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18800000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.41
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18775000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16298000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16298000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16298000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10482000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,50539000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,61021000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-44723000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2758000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,843000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1915000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-46638000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-271000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-46367000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-46367000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-46367000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59400000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.78
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59400000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.78
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59197000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.78
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,120550000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,120550000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,120550000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9680000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,51555000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,61235000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,59315000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2762000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,707000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2055000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,57260000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,205000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,57055000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,57055000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,57055000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59798000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.95
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68752000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.83
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60100000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.95
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19538000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19538000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19538000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11237000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52071000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,63308000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-43770000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2758000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1458000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1300000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-45070000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,28000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45098000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45098000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-45098000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60900000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.74
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60900000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.74
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60767000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:11:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.74
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24442000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24442000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24442000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12965000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,59924000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,72889000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-48447000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2755000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,113000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2642000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-51089000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,280000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51369000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-51369000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-51369000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60400000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.85
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60400000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.73
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60337000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.85
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28282000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28282000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28282000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11417000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,43650000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55067000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26785000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2777000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1416000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1361000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28146000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-305000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27841000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27841000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27841000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61900000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.45
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61900000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62184000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.45
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,89280000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,89280000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,89280000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10376000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52392000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62768000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,26512000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2438000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,129000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2309000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,24203000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-113000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,24316000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,24316000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,24316000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62582000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.39
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,69022000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.35
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62300000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:12:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.39
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30102000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30102000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30102000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11646000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40558000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52204000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22102000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2760000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,866000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1894000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23996000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,158000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24154000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24154000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24154000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63600000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63600000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62858000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,35525000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,35525000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,35525000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12586000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,50606000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,63192000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27667000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2750000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,217000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2533000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30200000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,189000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30389000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30389000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30389000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62400000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62400000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62744000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29442000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29442000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29442000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11530000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46732000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58262000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28820000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2375000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,645000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1730000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30550000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,60000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30610000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30610000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30610000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63800000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.48
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63800000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.48
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64037000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.48
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30268000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30268000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30268000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13425000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46981000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60406000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30138000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2757000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1031000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1726000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31864000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,48000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31912000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31912000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31912000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69400000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.46
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,69400000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.46
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,69638000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:14:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,40550000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,40550000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40550000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12953000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,50336000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,63289000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22739000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2769000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1106000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1663000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24402000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,57000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24459000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24459000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24459000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,76400000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,76400000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75891000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:10:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-100260000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,-100260000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-100260000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-37908000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-144049000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-181957000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,81697000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-7901000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2782000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5119000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,86816000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-165000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,86981000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,86981000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,86981000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.26
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.26
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.26
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31925000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,31925000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31925000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15550000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,56974000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,72524000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-40599000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2769000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2071000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-698000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-41297000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,99000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41396000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41396000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-41396000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,82800000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.5
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,82800000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.5
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82863000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.5
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43952000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43952000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43952000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15055000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52138000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,67193000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23241000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2750000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2645000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-105000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23346000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,75000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23421000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23421000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23421000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,83750000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,83750000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,83600000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:21:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29027000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29027000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29027000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15356000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,56443000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,71799000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-42772000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2739000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3079000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,340000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-42432000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,124000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42556000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42556000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-42556000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,84508000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.5
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,84508000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.5
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,85100000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 08:23:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.5
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-104904000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,-104904000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-104904000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-45961000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-165555000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-211516000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,106612000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-8258000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-7795000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,463000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,107075000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-298000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,107373000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,107373000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,107373000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.28
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.28
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.28
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24401000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24401000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,970000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,970000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23431000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,49603000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,54902000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,104505000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-81074000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,633000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3165000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2532000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-78542000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-194000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-78348000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-78348000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-78348000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,88000000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.89
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,88000000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.89
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,88219000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.89
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,191566000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,191566000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,191566000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,26739000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52008000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,78747000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,112819000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,736000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4125000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3389000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,116208000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,205000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,116003000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,116003000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,116003000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86445000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.34
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,91728000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.26
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,86600000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:21:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.34
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33174000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33174000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,242000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,242000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,32932000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,35823000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,49963000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,85786000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-52854000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,702000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4193000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3491000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-49363000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,76000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-49439000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-49439000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-49439000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,87007000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.57
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,87007000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.57
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,86700000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 08:23:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.57
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-249141000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,-249141000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-1212000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-1212000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-247929000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-112165000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-156873000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-269038000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21109000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2071000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-11483000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9412000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11697000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-87000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11784000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11784000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11784000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.12
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.12
